Dorian LPG
LPG
Ermenegildo Zegna NV
ZGN
Halozyme Therapeutics
HALO
4
DexCom
DXCM
5
Workday
WDAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -124.95%-4M | -224.32%-1.28M | -49.21%-536.67K | -105.29%-986.24K | -120.41%-1.2M | -49.39%-1.78M | 14.65%-394.01K | -24.01%-359.68K | -45.27%-480.41K | -408.00%-542.45K |
Net income from continuing operations | -1,241.77%-31.98M | -6,409.57%-27.12M | -506.28%-2.14M | -57.40%-1.61M | -87.81%-1.11M | -103.41%-2.38M | -5.74%-416.59K | -15.10%-353.67K | -204.98%-1.02M | -337.28%-588.9K |
Operating gains losses | --14.86M | --14.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 1,188.59%72.16K | 1,608.75%71.65K | -73.45%171 | -1,442.41%-5.13K | 1,335.70%5.47K | 532.77%5.6K | 373.79%4.19K | --644 | --382 | --381 |
Deferred tax | ---13.36K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | 50,849.85%667.44K | -274.07%-31.99K | 8,960.61%588.97K | 577.76%269.89K | -446.05%-159.42K | 107.16%1.31K | 126.80%18.38K | -138.59%-6.65K | -1,194.98%-56.49K | 65.17%46.07K |
-Change in receivables | ---59.78K | --13.33K | ---79.91K | --1.93K | --4.87K | --0 | --0 | --0 | --0 | --0 |
-Change in inventory | --455.1K | --117.54K | --185K | --3.8K | --148.77K | --0 | --0 | --0 | --0 | --0 |
-Change in prepaid assets | ---83.75K | --235.78K | ---66.11K | --123.72K | ---377.14K | --0 | --0 | --0 | --0 | --0 |
-Change in payables and accrued expense | 1,629.71%266.69K | -1,190.03%-363.91K | 1,474.75%246.04K | 339.72%330.83K | -48.88%53.72K | -114.51%-17.43K | -70.99%33.39K | 36.07%-17.9K | -2,775.09%-138.01K | 276.76%105.09K |
-Change in other current assets | 193.11%54.94K | 660.04%84.04K | 788.79%99.99K | -830.87%-82.22K | -516.59%-46.87K | 113.45%18.74K | 91.87%-15.01K | -75.12%11.25K | --11.25K | --11.25K |
-Change in other current liabilities | ---48.44K | ---15.38K | ---14.44K | ---14.03K | ---4.59K | --0 | --0 | --0 | --0 | --0 |
-Change in other working capital | --82.68K | ---103.4K | --218.4K | ---94.15K | 187.99%61.83K | ---- | ---- | ---- | ---- | ---70.27K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -124.95%-4M | -224.32%-1.28M | -49.21%-536.67K | -105.29%-986.24K | -120.41%-1.2M | -49.39%-1.78M | 14.65%-394.01K | -24.01%-359.68K | -45.27%-480.41K | -408.00%-542.45K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -26,853.26%-852.8K | 0 | 0 | 75 | -852.88K | -107.78%-3.16K | 0 | -316,500.00%-3.16K | 0 | 0 |
Net PPE purchase and sale | --0 | --0 | ---- | ---- | ---852.88K | 30.84%-3.16K | --0 | ---- | ---- | --0 |
Net business purchase and sale | ---852.8K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -26,853.26%-852.8K | --0 | --0 | --75 | ---852.88K | -107.78%-3.16K | --0 | -316,500.00%-3.16K | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,914.81%7.71M | 7,044.51%3.35M | 0 | 0 | 4.36M | -191.96%-424.93K | 45.08%-48.23K | -153.12K | -323.58%-223.58K | 0 |
Net common stock issuance | --7.05M | --2.05M | --0 | --0 | --5M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --1.52M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | -102.17%-859.09K | -359.04%-221.4K | --0 | --0 | ---637.69K | -383.84%-424.93K | ---48.23K | ---153.12K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,914.81%7.71M | 7,044.51%3.35M | --0 | --0 | --4.36M | -191.96%-424.93K | 45.08%-48.23K | ---153.12K | -323.58%-223.58K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -71.13%894.77K | 26.08%1.69M | 19.94%2.22M | 25.48%3.21M | -71.13%894.77K | -18.13%3.1M | -62.92%1.34M | -52.44%1.85M | -38.04%2.56M | -18.13%3.1M |
Current changes in cash | 229.84%2.86M | 568.42%2.07M | -4.01%-536.67K | -40.08%-986.16K | 526.55%2.31M | -221.16%-2.2M | 12.66%-442.25K | -77.89%-515.96K | -205.15%-703.99K | -259.26%-542.45K |
End cash Position | 319.92%3.76M | 319.92%3.76M | 26.08%1.69M | 19.94%2.22M | 25.48%3.21M | -71.13%894.77K | -71.13%894.77K | -62.92%1.34M | -52.44%1.85M | -38.04%2.56M |
Free cash flow | -124.55%-4M | -224.32%-1.28M | -47.91%-536.67K | 72.24%-133.36K | -277.64%-2.05M | -49.08%-1.78M | 15.03%-394.01K | -25.10%-362.84K | -45.27%-480.41K | -396.27%-542.45K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |